Trades on 1 secondary market
Insamo
Insamo is a biotechnology company building membrane-permeable, orally available cyclic peptides that combine the binding affinity of antibodies with the pharmacology of small molecules for drug discovery. Its platform automates the design, synthesis, and testing of peptides at large scale and applie
Insamo is an API provider whose private shares are listed on 1 secondary market: Nasdaq Private Market.
Where It Trades
Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.